Suitability evaluation of new endogenous biomarkers for the identification of nitrite-based urine adulteration in mass spectrometry methods.
Andrea Eva SteuerKim ArnoldDominique KamberThomas KraemerPublished in: Drug testing and analysis (2018)
Urine adulteration to circumvent positive drug testing is a fundamental challenge for toxicological laboratories all over the world. Untargeted mass spectrometry (MS) methods used in metabolomics had previously revealed uric acid (UA), histidine, methylhistidine, and their oxidation products, for example 5-hydroxyisourate (HIU) as potential biomarkers for urine adulteration using potassium nitrite (KNO2 ). These markers should be further evaluated for their reliability, stability, and routine applicability. Influence of KNO2 concentration, urinary pH, reaction time, and stability at room temperature, 4°C, and - 20°C was determined in urine under varying conditions. Analysis was performed after protein precipitation with acetonitrile by liquid chromatography-high resolution mass spectrometry (LC-HRMS). Receiver operating characteristics (ROC) analysis was applied for cut-off evaluation after biomarker quantification (n = 100 per group). Blinded measurements (n = 50) were performed to check the general applicability to identify adulterated samples under routine conditions. The higher the adulterant concentration, the lower the concentrations of histidine, methylhistidine, and UA. In return, amounts of their oxidation products increased. Highest changes were observed under weak acid conditions (pH 4-5). Storage at -20°C ensured sufficient stability for all oxidative markers over one month. ROC evaluated biomarker performance and application to unknown samples revealed satisfying results, with HIU as the most suitable biomarker (positive predictive value (PPV) 100%), followed by UA (PPV 93%). HIU and UA proved suitable markers to identify urine adulteration using KNO2 and are ready for implementation into routine MS procedures.
Keyphrases
- mass spectrometry
- liquid chromatography
- high resolution mass spectrometry
- tandem mass spectrometry
- gas chromatography
- ultra high performance liquid chromatography
- uric acid
- room temperature
- high performance liquid chromatography
- capillary electrophoresis
- simultaneous determination
- high resolution
- solid phase extraction
- nitric oxide
- metabolic syndrome
- primary care
- hydrogen peroxide
- ionic liquid
- quality improvement
- ms ms
- single cell
- multiple sclerosis
- electron transfer
- study protocol
- randomized controlled trial
- adverse drug
- small molecule
- gas chromatography mass spectrometry
- protein protein